kEA2x1 (Kallikrein inhibitor with external arginines)

General Information


DRACP ID  DRACP05532

Peptide Name   kEA2x1 (Kallikrein inhibitor with external arginines)

Sequence  XARCSDRFRNCPADEALCGR

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  All cysteines form disulfide bridges with the T3-scaffold.

N-terminal Modification  FITC

C-terminal Modification  Amidation

Other Modification  X=Ahx, 6-aminohexanoic acid

Chiral  L



Physicochemical Information


Formula  C84H136N32O27S3

Absent amino acids  HIKMQTVWY

Common amino acids  R

Mass  257147

Pl  8.05

Basic residues  4

Acidic residues  3

Hydrophobic residues  5

Net charge  1

Boman Index  -7586

Hydrophobicity  -76.5

Aliphatic Index  34.5

Half Life 
  /

Extinction Coefficient cystines  125

Absorbance 280nm  6.58

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24697151

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2374

DRACP is developed by Dr.Zheng's team.